479 related items for PubMed ID: 19055199
1. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[Abstract] [Full Text] [Related]
2. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[Abstract] [Full Text] [Related]
3. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE, Noonan MJ.
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[Abstract] [Full Text] [Related]
4. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[Abstract] [Full Text] [Related]
5. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M.
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[Abstract] [Full Text] [Related]
6. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[Abstract] [Full Text] [Related]
7. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H, Parasuraman B, Boggs R, Miller CJ, Leidy NK, O'Dowd L.
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[Abstract] [Full Text] [Related]
8. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
Drugs; 2006 Sep; 66(17):2235-54. PubMed ID: 17137405
[Abstract] [Full Text] [Related]
9. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC, Martin P, Mezzanotte WS.
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[Abstract] [Full Text] [Related]
10. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD.
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[Abstract] [Full Text] [Related]
11. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[Abstract] [Full Text] [Related]
12. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
Drugs; 2008 Oct; 68(14):1975-2000. PubMed ID: 18778120
[Abstract] [Full Text] [Related]
13. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ, Senn S, Mezzanotte WS.
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[Abstract] [Full Text] [Related]
14. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[Abstract] [Full Text] [Related]
15. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
Korenblat PE, Rosenwasser LJ.
Allergy Asthma Proc; 2010 Jun; 31(3):190-202. PubMed ID: 20482961
[Abstract] [Full Text] [Related]
16. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
Eid NS, Noonan MJ, Chipps B, Parasuraman B, Miller CJ, O'Brien CD.
Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
[Abstract] [Full Text] [Related]
17. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study.
Morice AH, Peterson S, Beckman O, Kukova Z.
Pulm Pharmacol Ther; 2008 Sep; 21(1):152-9. PubMed ID: 17376722
[Abstract] [Full Text] [Related]
18. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C.
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[Abstract] [Full Text] [Related]
19. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K.
Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
[Abstract] [Full Text] [Related]
20. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE.
Drugs; 2009 Nov; 69(5):549-65. PubMed ID: 19368417
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
